Caplin Steriles Ltd has received final approval from the United States Food and Drug Administration (USFDA) for an eye infection treatment drug. The approval received is for Ofloxacin Ophthalmic Solution, used in treating eye infection.
In the Q3FY24 meet the management had said that the H2FY24 will be better compared to H1FY24 due to commissioning of new plant/lines and also expected approvals of pending ANDAs also the holdings of institutions are steadily going up from last 4-5 quarters.
Disc : Not SEBI Registered. Not a buy/sell advice
Invested so can be biased
| Subscribe To Our Free Newsletter |
